Why Ultragenyx Pharmaceutical Stock Is Bouncing Back Today
While Pharmaceutical (NASDAQ: RARE) provided the market with disappointing news yesterday -- shares plunged more than 42% -- it appears that investors aren't completely writing off the company's potential as a developer of treatments for rare diseases. A firm's favorable view of Ultragenyx stock is motivating some investors to click the buy button today, helping the stock recover from its recent decline.
As of 2:51 p.m. ET, shares of Ultragenyx are up 13.2%.
Image source: Getty Images.
Source Fool.com
Ultragenyx Pharmaceutical Inc. Aktie
?
1,71 %
Starke Kaufsignale für Ultragenyx Pharmaceutical Inc.: Keine Sell-Einschätzungen, nur Buy-Einschätzungen.
Mit einem Kursziel von 55 € für Ultragenyx Pharmaceutical Inc., würde dies eine mehr als zweifache Steigerung des aktuellen Kurses von 19.63 € bedeuten.
